The Gerbode defect is a rare communication between the left ventricle (LV) and the right atrium (RA). It represents only 0.08% of intracardiac shunts and < 1% of all congenital heart defects [1]. Congenital LV-RA communication was first described in 1838 [2]. In 1958, Gerbode et al. [3] described the clinical features and successful surgical repair of five cases of LV-RA communication, characterized by a high ventricular septal defect associated with a defect in the tricuspid valve septal leaflet allowing blood to enter the RA from the LV. A review by Yuan [4] showed that congenital etiology represents 26.4% of cases and acquired etiology represents 72.7%. Among the acquired causes, the following stand out: postoperative cardiac surgery, infection, ischemic, iatrogenic, and traumatic.

We report an unusual case of Gerbode defect secondary to tricuspid valve endocarditis (Figure 1).

A 58-year-old male with systemic arterial hypertension, diabetes, diabetic retinopathy, dyslipidemia, and obesity, a non-user of illicit drugs, had a prolonged hospitalization for treatment of pulmonary tuberculosis in 2018 and, after that, had several hospitalizations for sepsis of pulmonary focus. In one of them, in 2019, he developed acute infective endocarditis due to multi-sensitive Staphylococcus aureus, related to a central venous catheter. At that time, a transthoracic echocardiogram showed a tricuspid valve with thickened leaflets and a small, mobile, hyperechoic, homogeneous mass on the atrial side of the septal leaflet measuring 4.6 cm, and moderate to severe insufficiency. Left ventricular ejection fraction was 46%, and the estimated pulmonary artery systolic pressure was 59 mmHg.

After resolution of the infectious condition with medical treatment, the patient was discharged asymptomatic and with complete resolution of the tricuspid vegetation image. During outpatient follow-up, he presented dyspnea on mild exertion, and consecutive echocardiograms demonstrated moderate tricuspid insufficiency, dilation of the right chambers, moderate dilation of the left atrium (LA), and severe pulmonary hypertension (pulmonary artery systolic pressure 83 mmHg). He was on regular use of losartan, amlodipine, hydrochlorothiazide, furosemide, metoprolol succinate, spironolactone, atorvastatin, metformin, and empagliflozin.

A transesophageal echocardiogram was performed, which demonstrated a 74% LV ejection fraction, enlargement of the right cavities and LA, communication between the LV (subaortic region) and the RA of 6 to 8 mm with a maximum gradient of 56 mmHg, left-to-right shunt (Figure 2), in addition to moderate tricuspid regurgitation and estimated pulmonary artery systolic pressure of 50 mmHg.

To evaluate suspected pulmonary arterial hypertension, the patient underwent both right and left heart catheterization. The findings revealed mild pulmonary hypertension, with a pulmonary artery systolic pressure of 42 mmHg (reference: 15–35 mmHg), right ventricular (RV) enlargement, and increased left ventricular end-diastolic volume. Additionally, contrast passage from the LV to the RA was observed, consistent with a Gerbode shunt. No angiographic evidence of pulmonary embolism. The right coronary artery had 30% stenosis.

The defect was surgically repaired by thoracotomy, and a communication orifice of approximately 1.5 cm was visualized intraoperatively, below the septal cusp of the tricuspid valve, with this cusp divided in half (Figure 3). The septal defect was closed with a bovine pericardial patch (Figure 4), and the leaflet was reconstructed, without perioperative complications.

The patient had a good clinical progress and was discharged from the hospital after 10 days. During outpatient follow-up, he reported improvement in the symptoms of dyspnea.

The Gerbode defect is rare, and its incidence has been increasing with the development of modern cardiac intervention techniques [4]. The classification of the defect depends on its anatomical relationships. In 1967, Riemenschneider and Moss [5] classified the Gerbode defect into two types: direct (or true) and indirect (or false). The direct type is a direct shunt between the LV and RA through the membranous septum, while the indirect type is an intraventricular communication with a left-to-right shunt at the ventricular level associated with tricuspid regurgitation, with the high-speed shunt directed to the RA [2, 4].

A subclassification categorizes indirect defects according to their location. Supravalvular defects involve the atrioventricular membranous septum and occur just above the insertion of the septal leaflet of the tricuspid valve. Infravalvular defects are the most common type and occur in the intraventricular membranous septum. This type is always associated with a malformation in the septal leaflet of the tricuspid valve. These defects include perforation, cleft, or widened commissures. The third and rarest type is the combined supravalvular and infravalvular defect [5]. In our patient, we found an indirect, infravalvular, acquired LV-RA communication due to tricuspid valve involvement in infective endocarditis.

Treatment of the acquired Gerbode defect depends on symptoms, magnitude of shunt, flow volume, concomitant anatomic abnormalities, and co-morbidities. Unlike our patient, asymptomatic, chronic small defects can be managed conservatively.

Percutaneous transcatheter closure techniques have been employed in almost 25% of patients, mostly in high-risk surgical candidates. In most of the cases, surgical correction with a simple direct suture might be enough to close the defect, or pericardial patch closure with sutures may be used, if necessary, such as in our case. If the Gerbode defect is associated with partial or complete destruction of the tricuspid valve, reconstruction or replacement of the tricuspid valve might be required [6].

While a congenital Gerbode defect affects younger patients and is frequently associated with other congenital cardiac anomalies [4, 7], the acquired defect affects older male patients [2] and most commonly occurs after cardiac surgery or percutaneous cardiac intervention (59.1%), and after infective endocarditis (28.4%). Lastly, the most frequent sites of infection are the aortic valve (40%) and the tricuspid valve (20%), and the most frequent microorganism is Staphylococcus (54%), followed by Streptococcus [4].

The pathophysiology of the Gerbode defect is based on the high-pressure gradient generated by the LV-RA shunt, leading to increased RA flow and dilation of the right chambers. Clinical manifestations can range from asymptomatic to severe heart failure (HF), depending on the volume and duration of the shunt [2, 8]. The most common symptom is dyspnea, which occurs due to congestion in the pulmonary circulation. It can present as left HF, and more frequently as right HF (fatigue, weakness, edema of the extremities). Fever and atrioventricular block are more common in the acquired defect [4].

The diagnosis is challenging, since it is a rare pathology, and transthoracic echocardiography has limited accuracy, especially in adults and patients with obesity and chest deformities. It is important to distinguish the high velocity LV to RA jet in Gerbode defect from conditions that increase pulmonary artery pressure and cause high velocity of the tricuspid regurgitation. Differentiation by echocardiography can be difficult, and the examination must be performed cautiously to prevent high systolic flow on Doppler from being falsely interpreted as tricuspid insufficiency and pulmonary arterial hypertension [6]. Transesophageal echocardiography is the most sensitive method for detecting LV-RA shunt, especially in patients with prosthetic valves [2]. Other diagnostic methods include cardiac catheterization, magnetic resonance imaging, and computed tomography angiography. Cardiac catheterization is important to quantify tricuspid regurgitation, clarify pulmonary artery hypertension, and investigate other conditions, such as pulmonary embolism and coronary artery disease [2].

For Gerbode defects with severe clinical manifestations, correct diagnosis and early treatment, especially in acquired cases, result in a better prognosis [1]. In our case, the diagnosis was unclear, and no obvious cause was found for pulmonary hypertension until a transesophageal echocardiogram was performed. At first, we were concerned about the surgical indication due to obesity and associated risks. After intense communication, a shared and patient-centered decision was to perform surgery. Since the tricuspid valve leaflet was affected by endocarditis, it was necessary to reconstruct the leaflet in addition to closing the shunt using a pericardial patch.

In conclusion, the Gerbode defect is rare, and the acquired form accounts for most of the reported cases. Diagnosis can be challenging because it mimics other pathologies such as tricuspid regurgitation and pulmonary artery hypertension. Its differentiation and diagnostic definition are made through imaging tests. Transesophageal echocardiography can add important information, such as the location of the defect and the flow gradient, although sophisticated imaging techniques (magnetic resonance imaging and computed tomography angiography) may be required in challenging cases. Treatment consists of closing the defect when refractory symptoms or complications arise, mainly in acquired shunts, as they are frequently associated with HF. The reported case was surgically corrected, with a good result and favorable evolution.